The company has posted a revenue growth of 76 per cent year on year to Rs 28 crore while PAT witnessed a 91 per cent YoY increase supported by cost control and optimised interest expenses.
Curis Lifesciences aims higher exports to Africa, West Asia next fiscal
The Economy Times Industry1 hrs ago
24


AlterNet
RadarOnline
The Conversation
Raw Story
WFMJ-TV Politics